Market Research > Healthcare > OTC Drugs: U.S. Competitor Cost Structures

Market Research Reports: OTC Drugs

OTC Drugs: U.S. Competitor Cost Structures
Published August 2016
Base Years: 2013, 2014, and 2015

Download Brochure Price & Ordering
  • Description
  • Regional Coverage: United States
    Request Fact Sheet


    This report is an accurate and comprehensive examination of competitor cost structures of leading OTC marketers, focusing on key trends, developments, and business opportunities.

    This Report is Designed to:

    • Offer subscribers a benchmark for OTC industry cost structures
    • Reveal profit and loss line items for each players’ OTC business and their largest OTC product classes
    • Assess the cost positions of market leaders including Johnson & Johnson, Bayer Group, Pfizer, and GlaxoSmithKline
    • Understand the impact of industry consolidation on OTC cost structures
    • Understand how key competitors’ OTC cost structures compare to your own
    • Understand the impact of product recalls on cost structures
    • Give subscribers critical insights in order to succeed in the face of intensifying cost pressures
    • Provide an appraisal of expected future performance
  • Contents
  • Introduction

    Executive Summary
    • State of the industry
    • Major shifts in costs for the industry
    • Market sales and growth
    • Industry cost structure
    • Key factors influencing profitability
    • Analysis of key expenses
    • Product class cost structures (for those listed in Table 1)
    • Historical perespective
    • Appraisal and outlook
    Company Profiles
    For each of the companies profiled (listed in Table 2), the report provides information on profitability for its OTC business unit and leading product classes (illustrated in Table 3 and Table 4) and includes:
    • Business unit cost structure
    • Profitability
    • Cost structure of leading product classes
    • Corporate overview
    • Corporate sales and profits
    • Analysis of key expenses
    • Appraisal
    * Subject to charter subscriber input

    Table 1: Product Classes Covered
    Cough and cold preparations Topical products
    Digestive products Upper respiratory products
    Feminine products Other products, including home diagnostic test kits,
    sleeping aids, smoking cessation aids, and
    weight loss medications
    Internal analgesics  
    Nutritional products  

    Table 2: Companies Profiled
    Bayer Group Pfizer
    Carlyle Group Prestige Brands
    Church & Dwight Procter & Gamble
    GlaxoSmithKline Reckitt Benckiser
    Johnson & Johnson Sanofi

    Table 3: Cost Structure of the OTC Business
    Line item % Of net sales
      Trade promotion
      Raw Materials
      Consumer promotions
      Marketing department
      Sales force/sampling
      Research and development

    Table 4: Product Classes Profiled by Company
    Company Classes profiled
    Bayer Group Upper respiratory products, internal analgesics, nutritional products
    Carlyle Group Nutritional products
    Church & Dwight Nutritional products, other products, topical products
    GlaxoSmithKline/Novartis Digestive products, topical products, upper respiratory products, other products
    Johnson & Johnson Upper respiratory products, internal analgesics, topical products, other products
    Perrigo Internal analgesics, digestive products, upper respiratory products
    Pfizer Internal analgesics, upper respiratory products, nutritional products
    Prestige Brands Upper respiratory products, internal analgesics, feminine products
    Procter & Gamble Upper respiratory products, digestive products, other products
    Reckitt Benckiser Upper respiratory products, nutritional products, feminine products
    Sanofi Upper respiratory products, topical products, other products
  • Scope
  • OTC Drugs: U.S. Competitor Cost Structures has been successfully completed nine times before and was last published in July 2013. The report presents information on the financial performance, profitability, and costs structures of the 11 leading OTC companies in the United States. It is designed to help OTC pharmaceutical companies benchmark their cost structures with those of their competitors. For each company, cost breakdowns are provided for its overall OTC business, as well as its leading product classes.

    Company profiles also feature overviews of each company’s OTC business unit, an assessment of domestic OTC sales by product class, and analysis of costs, expenses, and profitability.

    Cost structures refer to U.S. operations only. Sales, expenses, and profits are presented for 2013, 2014, and 2015 and do not include extraordinary or nonrecurring items reports in published financial statements. References to overall corporate results are for the latest fiscal year available. Companies, product classes, and line items covered in this analysis are shown in the Table of Contents on the previous page.

  • Key Benefits
  • This study provides subscribers with accurate and concise profitability information and cost structures of 11 major OTC marketers in the United States. It is designed to help nonprescription drugs firms benchmark their cost structures with those of their competitors. Specifically, this report assists subscribers by providing:

    • Line-item detail to allow companies to benchmark their business against that of competitors
    • Details on how OTC marketers structure and run their operations
    • Competitive intelligence that helps companies make decisions to take steps to lower costs
    • Insights into decisions companies have made regarding outsourcing, resource allocation, and product portfolios
    • Important comparisons of marketers’ cost structures between 2013-2015 and understanding key shifts in costs over this timeframe for major OTC marketers
  • Methodology
  • Kline’s approach places the principal emphasis on primary research techniques to ensure that the foundation of business intelligence and insight is accurate, current, and reliable. Building on our 50-plus years in the business and leveraging our worldwide network of offices, our teams of seasoned professionals draw upon pragmatic industrial and commercial experience to understand and interpret global impacts and local perspectives.

    Primary Research
    We Know Who to Talk to. We Know How to Listen.

    A high number of in-depth discussions are conducted by each analyst. Up to 60% of interviews are done with the true industry insiders!

    Kline’s analysts draw upon pragmatic experience to understand global impacts and local perspectives. Our interviews engage experts across all pertinent fields and sectors including:

    • Marketers/manufacturers
    • Wholesalers
    • Raw material suppliers
    • Retailers
    • Advertising agencies
    • Trade organizations
    • Packaging suppliers
    • Industry consultants

    Secondary Research
    We Know Where to Look – Mining the Details.

    Analysis is further supplemented by secondary research, consisting of constant tracking of annual company reports, national statistics bureaux, trade/ industrial/professional associations and the like.

    Relevant developments are diligently followed and their impact closely monitored. Reports also draw upon non-confidential data from Kline’s internal database, consisting of over half a century’s syndicated research.

    Comprehensive Market Intelligence
    We Know How to Verify.

    Data are rigorously analyzed, cross-checked, distilled and validated. Kline’s proven methodology allows exceptionally effective, precise and reliable market intelligence procurement and assessment, giving subscribers a solid foundation on which to grow, refine and expand their business with confidence.

    Kline Credentials

    Kline is a leading global management consulting and market research firm offering the complete spectrum of services. The firm has served the management consulting and market research needs of organizations in the chemicals, materials, energy, life sciences, and consumer products industries for over 50 years.

Share this: Email This Page

Related Reports
Nonprescription Drugs USA
Personal Care: U.S. Competitor Cost Structures
50 Years of OTC Research
An evolution of the U.S. OTC market since 1963 >>

Industry Expert

Laura Mahecha   Laura Mahecha

Sales Contacts

Pilar Pardo   Pilar Pardo
Kristy Altenburg   Kristy Altenburg
Contact Kline Market Research   View all contacts
Market Research Reports   Purchase a Report
  Healthcare Portfolio
  Knowledge Hub
Custom Research
Can’t find exactly what you’re looking for? Consider a custom report.